Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Genes and Proteins Associated with the Tumor Microenvironment Are Differentially Expressed in Cured Versus Primary Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma.

Johan Linderoth, MD, Patrik Edén, PhD, Mats Ehinger, MD PhD, Jeanette Valcich, Mats Jerkeman, MD PhD, Pär-Ola Bendahl, PhD, Mattias Berglund, PhD, Gunilla Enblad, MD PhD, Martin Erlanson, MD PhD, Göran Roos, MD PhD, Eva Cavallin-Ståhl, MD PhD

Blood (2007) 110 (11): 3171.

https://doi.org/10.1182/blood.V110.11.3171.3171

Published: 2007

Journal Articles

Subtype preference of the BCL6 397G/C polymorphism in germinal-center and non-germinal-center subtypes of diffuse large B-cell lymphoma

Mattias Berglund, Rose-Marie Amini, Majlis Book, Richard Rosenquist, Göran Roos, Ulf Thunberg

Blood (2006) 108 (10): 3623–3624.

https://doi.org/10.1182/blood-2006-06-032367

Published: 2006

Journal Articles

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Blood (2006) 107 (7): 2889–2894.

https://doi.org/10.1182/blood-2005-06-2227

Published: 2006

Includes: Supplemental data

Journal Articles

Short Telomeres Are Associated with Genetic Instability and the Occurrence of High Risk Genomic Aberrations in Chronic Lymphocytic Leukemia.

Alexander Kröber, MD, Pawel Grabowski, MD, Andreas Bühler, Till Seiler, MD, Hartmut Döhner, MD, Richard Rosenquist, MD, Göran Roos, MD, Stephan Stilgenbauer, MD

Blood (2005) 106 (11): 1178.

https://doi.org/10.1182/blood.V106.11.1178.1178

Published: 2005

Journal Articles

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

Mattias Berglund, Ulf Thunberg, Göran Roos, Richard Rosenquist, Gunilla Enblad

Blood (2005) 105 (12): 4894–4895.

https://doi.org/10.1182/blood-2004-12-4814

Published: 2005

Journal Articles

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Pawel Grabowski, Magnus Hultdin, Karin Karlsson, Gerard Tobin, Anna Åleskog, Ulf Thunberg, Anna Laurell, Christer Sundström, Richard Rosenquist, Göran Roos

Blood (2005) 105 (12): 4807–4812.

https://doi.org/10.1182/blood-2004-11-4394

Published: 2005

Journal Articles

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Karin Karlsson, Fiona Murray, Anna Laurell, Kerstin Willander, Gunilla Enblad, Mats Merup, Juhani Vilpo, Gunnar Juliusson, Christer Sundström, Ola Söderberg, Göran Roos, Richard Rosenquist

Blood (2004) 104 (9): 2879–2885.

https://doi.org/10.1182/blood-2004-01-0132

Published: 2004

Journal Articles

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Gerard Tobin, Ulf Thunberg, Anna Johnson, Inger Eriksson, Ola Söderberg, Karin Karlsson, Mats Merup, Gunnar Juliusson, Juhani Vilpo, Gunilla Enblad, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2003) 101 (12): 4952–4957.

https://doi.org/10.1182/blood-2002-11-3485

Published: 2003

Journal Articles

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Blood (2003) 101 (10): 4047–4054.

https://doi.org/10.1182/blood-2002-11-3479

Published: 2003

Journal Articles

Somatically mutated Ig V H 3-21 genes characterize a new subset of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Anna Johnson, Ingrid Thörn, Ola Söderberg, Magnus Hultdin, Johan Botling, Gunilla Enblad, Jan Sällström, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2002) 99 (6): 2262–2264.

https://doi.org/10.1182/blood.V99.6.2262

Published: 2002

Journal Articles

CD38 expression is a poor predictor for V H gene mutational status and prognosis in chronic lymphocytic leukemia

Ulf Thunberg, Anna Johnson, Göran Roos, Ingrid Thörn, Gerard Tobin, Jan Sällström, Christer Sundström, Richard Rosenquist

Blood (2001) 97 (6): 1892–1894.

https://doi.org/10.1182/blood.V97.6.1892

Published: 2001

Journal Articles

Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas—Prognostic Implications

Martin Erlanson, Cajsa Portin, Barbro Linderholm, Jack Lindh, Göran Roos, Göran Landberg

Blood (1998) 92 (3): 770–777.

https://doi.org/10.1182/blood.V92.3.770

Published: 1998

Journal Articles

Telomerase Activity in Hodgkin's Disease

Karl-Fredrik Norrback, Gunilla Enblad, Martin Erlanson, Christer Sundström, Göran Roos

Blood (1998) 92 (2): 567–573.

https://doi.org/10.1182/blood.V92.2.567

Published: 1998

NARROW

Genes and Proteins Associated with the Tumor Microenvironment Are Differentially Expressed in Cured Versus Primary Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma.

Subtype preference of the BCL6 397G/C polymorphism in germinal-center and non-germinal-center subtypes of diffuse large B-cell lymphoma

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Short Telomeres Are Associated with Genetic Instability and the Occurrence of High Risk Genomic Aberrations in Chronic Lymphocytic Leukemia.

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Mutated V H genes and preferential V H 3-21 use define new subsets of mantle cell lymphoma

Somatically mutated Ig V H 3-21 genes characterize a new subset of chronic lymphocytic leukemia

CD38 expression is a poor predictor for V H gene mutational status and prognosis in chronic lymphocytic leukemia

Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas—Prognostic Implications

Telomerase Activity in Hodgkin's Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only